Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2022960910;60911;60912 chr2:178591040;178591039;178591038chr2:179455767;179455766;179455765
N2AB1858855987;55988;55989 chr2:178591040;178591039;178591038chr2:179455767;179455766;179455765
N2A1766153206;53207;53208 chr2:178591040;178591039;178591038chr2:179455767;179455766;179455765
N2B1116433715;33716;33717 chr2:178591040;178591039;178591038chr2:179455767;179455766;179455765
Novex-11128934090;34091;34092 chr2:178591040;178591039;178591038chr2:179455767;179455766;179455765
Novex-21135634291;34292;34293 chr2:178591040;178591039;178591038chr2:179455767;179455766;179455765
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: T
  • RefSeq wild type transcript codon: ACA
  • RefSeq wild type template codon: TGT
  • Domain: Fn3-34
  • Domain position: 59
  • Structural Position: 89
  • Q(SASA): 0.2896
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
T/A rs747588848 None 0.055 N 0.439 0.187 0.20549828249 gnomAD-4.0.0 2.73735E-06 None None None None N None 0 0 None 0 2.52169E-05 None 0 0 2.69885E-06 0 0
T/I None None 0.124 N 0.512 0.166 0.259761712551 gnomAD-4.0.0 1.59205E-06 None None None None N None 0 0 None 0 0 None 0 0 2.85987E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
T/A 0.1097 likely_benign 0.1274 benign -0.861 Destabilizing 0.055 N 0.439 neutral N 0.486132131 None None N
T/C 0.2532 likely_benign 0.2672 benign -0.35 Destabilizing 0.968 D 0.647 neutral None None None None N
T/D 0.5113 ambiguous 0.6175 pathogenic -0.166 Destabilizing 0.726 D 0.627 neutral None None None None N
T/E 0.3356 likely_benign 0.4333 ambiguous -0.031 Destabilizing 0.726 D 0.585 neutral None None None None N
T/F 0.3752 ambiguous 0.4691 ambiguous -0.753 Destabilizing 0.396 N 0.695 prob.neutral None None None None N
T/G 0.2383 likely_benign 0.2769 benign -1.218 Destabilizing 0.567 D 0.635 neutral None None None None N
T/H 0.3035 likely_benign 0.3683 ambiguous -1.219 Destabilizing 0.968 D 0.697 prob.neutral None None None None N
T/I 0.2408 likely_benign 0.3024 benign 0.044 Stabilizing 0.124 N 0.512 neutral N 0.488841156 None None N
T/K 0.1888 likely_benign 0.2504 benign -0.12 Destabilizing 0.497 N 0.586 neutral N 0.486132131 None None N
T/L 0.0648 likely_benign 0.077 benign 0.044 Stabilizing 0.001 N 0.342 neutral None None None None N
T/M 0.0766 likely_benign 0.0854 benign -0.004 Destabilizing 0.026 N 0.393 neutral None None None None N
T/N 0.1212 likely_benign 0.1381 benign -0.527 Destabilizing 0.726 D 0.512 neutral None None None None N
T/P 0.0839 likely_benign 0.1083 benign -0.226 Destabilizing 0.859 D 0.633 neutral N 0.498202317 None None N
T/Q 0.1917 likely_benign 0.2215 benign -0.401 Destabilizing 0.567 D 0.647 neutral None None None None N
T/R 0.1568 likely_benign 0.2058 benign -0.19 Destabilizing 0.497 N 0.63 neutral N 0.475394483 None None N
T/S 0.1611 likely_benign 0.1907 benign -0.889 Destabilizing 0.22 N 0.422 neutral N 0.486688336 None None N
T/V 0.1711 likely_benign 0.1964 benign -0.226 Destabilizing 0.157 N 0.439 neutral None None None None N
T/W 0.6451 likely_pathogenic 0.7468 pathogenic -0.81 Destabilizing 0.968 D 0.696 prob.neutral None None None None N
T/Y 0.3445 ambiguous 0.4228 ambiguous -0.445 Destabilizing 0.726 D 0.709 prob.delet. None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.